acelity  home acelity site navigation investors leadership partners suppliers newsroom news releases customers cms competitive bidding frequently asked questions ordering recycling  disposal careers search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information kci express® products products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology featured products tielle™ dressing family activac™ therapy system with ion progress™ remote therapy monitoring biosorb™ gelling fiber dressing vaculta™ negative pressure wound therapy system promogran prisma™ matrix prevena™ incision management system healthcare professionals healthcare professionals overview medical education reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients patients overview patient stories about about overview compliance mission and values our brands  core technologies citizenship  responsibility history  innovation leadership menu search acelity products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology healthcare professionals overview medical education overview medical education programs reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients overview patient stories about overview compliance mission and values our brands  core technologies citizenship  responsibility overview corporate social responsibility history  innovation leadership overview leadership team board of directors investors overview leadership partners overview suppliers overview supplier diversity newsroom overview news releases customers overview cms competitive bidding frequently asked questions ordering overview kci express® recycling  disposal careers overview search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information overview kci express® overview close menu latest news acelity news headline displays featured article title as link we know collagen thats why we added something important orc learn more › learn more › learn more › learn more › learn more › make better our brands our products boldly advancing the science of healing healthcare professionals discover how our innovative approach to healing and unrivalled portfolio help patients heal our commitment is to deliver proven endtoend solutions that reduce costs and create economic value learn more patients  their caregivers helping patients become whole through proven technologies and solutions we currently serve patients in  countries including many where advanced products are only recently becoming available learn more careers careers investors investors partners  distributors partners  distributors dsltestdsl you are leaving acelitycom you are now leaving the acelitycom web site links to other sites are provided as a convenience to users these sites are not affiliated with acelity and acelity accepts no responsibility for their content continue cancel footer navigation healthcare professionals reimbursement instructions for use submit an idea education patient information patient resources patient stories about acelity contact careers brands  core technologies leadership tools kci express® patient bill pay ion healing™ mobile app coding guidelines vac® therapy insurance form message for patients terms of use privacy policy sitemap accessibility help copyright   kci licensing all rights reserved the information included in this web site has been prepared and intended for residents of the united states of america this web site contains information about products which may or may not be available in different countries and if applicable may or may not have received approval or market clearance by a governmental regulatory body for different indications for use please consult individual country sites for approved uses and any applicable restrictions the information on this site is intended for healthcare professionals patients should consult with their healthcare professional providers regarding their specific medical conditions and treatments as well as the information provided on this site including the risks and benefits of certain products and services that may be discussed on this site acelity  wound management acelity site navigation investors leadership partners suppliers newsroom news releases customers cms competitive bidding frequently asked questions ordering recycling  disposal careers search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information kci express® products products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology featured products tielle™ dressing family activac™ therapy system with ion progress™ remote therapy monitoring biosorb™ gelling fiber dressing vaculta™ negative pressure wound therapy system promogran prisma™ matrix prevena™ incision management system healthcare professionals healthcare professionals overview medical education reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients patients overview patient stories about about overview compliance mission and values our brands  core technologies citizenship  responsibility history  innovation leadership menu search acelity products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology healthcare professionals overview medical education overview medical education programs reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients overview patient stories about overview compliance mission and values our brands  core technologies citizenship  responsibility overview corporate social responsibility history  innovation leadership overview leadership team board of directors investors overview leadership partners overview suppliers overview supplier diversity newsroom overview news releases customers overview cms competitive bidding frequently asked questions ordering overview kci express® recycling  disposal careers overview search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information overview kci express® overview close menu wound management wound management diabetic foot ulcers pressure ulcers venous leg ulcers acute  traumatic wounds infected wounds enteric fistulas wound management wound management diabetic foot ulcers pressure ulcers venous leg ulcers acute  traumatic wounds infected wounds enteric fistulas wound management helping patients heal why it matters clinician resources view all products home products wound management helping patients heal our focus is to make patients better our products have been clinically evaluated and shown to facilitate healing in the hospital or the home acelity has developed a comprehensive range of products and therapies for a wide variety of wounds the science behind our products our solutions are built on deep scientific expertise supported by a large body of clinical evidence product technology clinical evidence why it matters chronic wounds represent a large and growing threat to public health in the us alone they affect over  million people as the population ages that burden will increase – made worse by rising healthcare costs and the growing incidences of diabetes and obesity   at acelity we help improve the lives of patients through innovation we are also researching and documenting the value of our products in terms of individual and public benefit this research helps to inform policy and decisionmakers by providing a systematic way to evaluate different treatments   diabetic foot ulcers every  seconds a leg is amputated globally due to diabetes for patients diagnosed with diabetes mellitus the lifetime risk of developing a foot ulcer may be as high as  of this  of diabetic foot ulcers progress to amputation accounting for  of nontraumatic amputations   explore focus area   featured products snap™ therapy system promogran prisma™ matrix activac™ therapy system pressure ulcers a pressure ulcer also known as a bed sore pressure sore or decubitus ulcer is a localized injury to the skin andor underlying tissue which may be caused by unrelieved pressure on the skin    these pressure induced skin injuries range from non blanchable erythema of intact skin to deep ulcers extending to the bone where ulceration may be determined by the degree and duration of pressure and may be characterized by deep tissue necrosis it usually occurs over a bony prominence as a result of pressure shear or friction acelity offers a comprehensive range of products for the management of pressure ulcers   explore focus area   featured products snap™ therapy system promogran prisma™ matrix activac™ therapy system venous leg ulcers venous ulcers are most commonly found below the knee and above the ankle and often have a larger surface area but are shallower in depth than other ulcers the leg may become swollen causing the skin surrounding the ulcer to become dry itchy and sometimes brownish in color   explore focus area featured products snap™ therapy system dynaflex™ compression system vaculta™ therapy system acute  traumatic wounds acute wounds are disruptions to the integrity of the skin and underlying tissues that with proper care and control heal in a timely and uneventful manner traumatic wounds result from injury to hard andor soft tissue and include damage to bone muscle ligament and tendons including partial thickness burns and orthopedic wounds   explore focus area featured products vaculta™ therapy system tielle™ plus dressing adaptic™ dressing infected wounds infected wounds cant wait every infected wound requires a comprehensive treatment plan to help manage the wound and reestablish an environment for healing   explore focus area featured products vaculta™ therapy system vac® granufoam silver™ dressings silvercel™ nonadherent dressing enteric fistulas fistulas are an abnormal connection between two or more structures or spaces fistulas are usually the result of injury or surgery but also can result from infection or inflammation managing patients with fistulas is challenging and represents a significant unmet need   explore focus area   featured products fistula solution® devices clinician resources acelity offers a wide range of wound healing solutions such as vac® therapy and advanced wound dressings acelity is a trusted partner offering clinically proven economically beneficial wound healing therapies designed to deliver positive outcomes for patients and healthcare professionals   learn more for clinicians chronic wounds solutions brochure vac® therapy essentials acelity wound selection guide tielle™ dressing family overview healthcare professionals for patients patient resources vac® therapy patient guide vacvia™ patient guide cellutome™ patient brochure a patient’s perspective patients help others by sharing their stories on how acelity products have helped them patients stories   click here to view references  sen et al wound repair regen    –     singh n armstrong dg lipsky ba preventing foot ulcers in patients with diabetes jama  jan  review   dsldslus you are leaving acelitycom you are now leaving the acelitycom web site links to other sites are provided as a convenience to users these sites are not affiliated with acelity and acelity accepts no responsibility for their content continue cancel footer navigation healthcare professionals reimbursement instructions for use submit an idea education patient information patient resources patient stories about acelity contact careers brands  core technologies leadership tools kci express® patient bill pay ion healing™ mobile app coding guidelines vac® therapy insurance form message for patients terms of use privacy policy sitemap accessibility help copyright   kci licensing all rights reserved the information included in this web site has been prepared and intended for residents of the united states of america this web site contains information about products which may or may not be available in different countries and if applicable may or may not have received approval or market clearance by a governmental regulatory body for different indications for use please consult individual country sites for approved uses and any applicable restrictions the information on this site is intended for healthcare professionals patients should consult with their healthcare professional providers regarding their specific medical conditions and treatments as well as the information provided on this site including the risks and benefits of certain products and services that may be discussed on this site acelity  products acelity site navigation investors leadership partners suppliers newsroom news releases customers cms competitive bidding frequently asked questions ordering recycling  disposal careers search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information kci express® products products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology featured products tielle™ dressing family activac™ therapy system with ion progress™ remote therapy monitoring biosorb™ gelling fiber dressing vaculta™ negative pressure wound therapy system promogran prisma™ matrix prevena™ incision management system healthcare professionals healthcare professionals overview medical education reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients patients overview patient stories about about overview compliance mission and values our brands  core technologies citizenship  responsibility history  innovation leadership menu search acelity products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology healthcare professionals overview medical education overview medical education programs reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients overview patient stories about overview compliance mission and values our brands  core technologies citizenship  responsibility overview corporate social responsibility history  innovation leadership overview leadership team board of directors investors overview leadership partners overview suppliers overview supplier diversity newsroom overview news releases customers overview cms competitive bidding frequently asked questions ordering overview kci express® recycling  disposal careers overview search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information overview kci express® overview close menu products our products wound management open abdomen management incision management epidermal harvesting animal health product technology product catalog our products our products wound management open abdomen management incision management epidermal harvesting animal health product technology product catalog our products our extensive portfolio of innovative healing solutions is trusted by healthcare professionals around the world search acelity clinical solutions featured products science  research view all products home products clinical solutions explore the acelity portfolio of solutions for specific clinical applications wound management wound management open abdomen management open abdomen management epidermal harvesting epidermal harvesting incision management incision management animal health animal health featured products tielle™ dressing family ion progress™ biosorb™ gelling fiber dressing vaculta™ therapy system promogran prisma™ matrix prevena™ therapy view all products science  research the science behind our products our solutions are built on a deep understanding of wound healing and supported by a large body of clinical evidence product technology inspired innovation wherever we work our objective is to deliver costeffective products and techniques that help promote healing and reduce complications to transform lives for the better this benefits patients their caregivers and society as a whole   read more dslprarus en you are leaving acelitycom you are now leaving the acelitycom web site links to other sites are provided as a convenience to users these sites are not affiliated with acelity and acelity accepts no responsibility for their content continue cancel footer navigation healthcare professionals reimbursement instructions for use submit an idea education patient information patient resources patient stories about acelity contact careers brands  core technologies leadership tools kci express® patient bill pay ion healing™ mobile app coding guidelines vac® therapy insurance form message for patients terms of use privacy policy sitemap accessibility help copyright   kci licensing all rights reserved the information included in this web site has been prepared and intended for residents of the united states of america this web site contains information about products which may or may not be available in different countries and if applicable may or may not have received approval or market clearance by a governmental regulatory body for different indications for use please consult individual country sites for approved uses and any applicable restrictions the information on this site is intended for healthcare professionals patients should consult with their healthcare professional providers regarding their specific medical conditions and treatments as well as the information provided on this site including the risks and benefits of certain products and services that may be discussed on this site acelity  investors acelity site navigation investors leadership partners suppliers newsroom news releases customers cms competitive bidding frequently asked questions ordering recycling  disposal careers search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information kci express® products products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology featured products tielle™ dressing family activac™ therapy system with ion progress™ remote therapy monitoring biosorb™ gelling fiber dressing vaculta™ negative pressure wound therapy system promogran prisma™ matrix prevena™ incision management system healthcare professionals healthcare professionals overview medical education reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients patients overview patient stories about about overview compliance mission and values our brands  core technologies citizenship  responsibility history  innovation leadership menu search acelity products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology healthcare professionals overview medical education overview medical education programs reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients overview patient stories about overview compliance mission and values our brands  core technologies citizenship  responsibility overview corporate social responsibility history  innovation leadership overview leadership team board of directors investors overview leadership partners overview suppliers overview supplier diversity newsroom overview news releases customers overview cms competitive bidding frequently asked questions ordering overview kci express® recycling  disposal careers overview search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information overview kci express® overview close menu investors investors home investors our company acelity is a leading global medical technology company committed to restoring people’s lives through the development and commercialization of advanced wound care acelity lp inc and its subsidiaries leverage the strengths of kinetic concepts inc and systagenix wound management limited our mission is to change the clinical practice of medicine with solutions that speed healing reduce complications create economic value and improve patients’ lives   we are global pioneers in advanced wound care creating and growing new markets based on our ability to identify and address unmet clinical needs with products that advance the practice of medicine beginning with our introduction of groundbreaking negative pressure wound therapy or npwt more than  years ago available in more than  countries we offer a broad range of products that can be used across clinical applications care settings and clinician groups to improve clinical outcomes and reduce overall costs of care our product offerings are backed by an extensive body of scientific clinical and economic outcomes data that demonstrate their clinical efficacy and value proposition by offering a range of complementary solutions that are often used together or in sequence across multiple care settings we are able to address patients’ needs throughout the healing process and offer healthcare providers a single source to address them we have maintained our market leadership by capitalizing on our differentiated and bestinclass product offerings utilizing our highly trained sales force robust service infrastructure and strong clinical reputation   acelity is headquartered in san antonio and employs nearly  people around the world   primary ir contact caleb moore vice president treasurer and investor relations acelity lp inc  interstate  west san antonio tx  email     information sec filings bondholder access request form code of ethics for chief executive and senior financial officers financial statements     xbrl data files contact us contact us leadership learn more newsroom newsroom you are leaving acelitycom you are now leaving the acelitycom web site links to other sites are provided as a convenience to users these sites are not affiliated with acelity and acelity accepts no responsibility for their content continue cancel footer navigation healthcare professionals reimbursement instructions for use submit an idea education patient information patient resources patient stories about acelity contact careers brands  core technologies leadership tools kci express® patient bill pay ion healing™ mobile app coding guidelines vac® therapy insurance form message for patients terms of use privacy policy sitemap accessibility help copyright   kci licensing all rights reserved the information included in this web site has been prepared and intended for residents of the united states of america this web site contains information about products which may or may not be available in different countries and if applicable may or may not have received approval or market clearance by a governmental regulatory body for different indications for use please consult individual country sites for approved uses and any applicable restrictions the information on this site is intended for healthcare professionals patients should consult with their healthcare professional providers regarding their specific medical conditions and treatments as well as the information provided on this site including the risks and benefits of certain products and services that may be discussed on this site acelity  usa contact information acelity site navigation investors leadership partners suppliers newsroom news releases customers cms competitive bidding frequently asked questions ordering recycling  disposal careers search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information kci express® products products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology featured products tielle™ dressing family activac™ therapy system with ion progress™ remote therapy monitoring biosorb™ gelling fiber dressing vaculta™ negative pressure wound therapy system promogran prisma™ matrix prevena™ incision management system healthcare professionals healthcare professionals overview medical education reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients patients overview patient stories about about overview compliance mission and values our brands  core technologies citizenship  responsibility history  innovation leadership menu search acelity products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology healthcare professionals overview medical education overview medical education programs reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients overview patient stories about overview compliance mission and values our brands  core technologies citizenship  responsibility overview corporate social responsibility history  innovation leadership overview leadership team board of directors investors overview leadership partners overview suppliers overview supplier diversity newsroom overview news releases customers overview cms competitive bidding frequently asked questions ordering overview kci express® recycling  disposal careers overview search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information overview kci express® overview close menu usa contact information home usa contact information acelity and kci headquarters  w interstate  san antonio tx  contact us by mail po box  san antonio tx      for customers for patients for investors for jobseekers for media customer support customer support for kci and systagenix products phone    hours  hours per day  days a week kci express phone    ext  email kciexpresskcicom contact customer support acelity is committed to providing quality customer service send an email acelity  healthcare professionals acelity site navigation investors leadership partners suppliers newsroom news releases customers cms competitive bidding frequently asked questions ordering recycling  disposal careers search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information kci express® products products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology featured products tielle™ dressing family activac™ therapy system with ion progress™ remote therapy monitoring biosorb™ gelling fiber dressing vaculta™ negative pressure wound therapy system promogran prisma™ matrix prevena™ incision management system healthcare professionals healthcare professionals overview medical education reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients patients overview patient stories about about overview compliance mission and values our brands  core technologies citizenship  responsibility history  innovation leadership menu search acelity products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology healthcare professionals overview medical education overview medical education programs reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients overview patient stories about overview compliance mission and values our brands  core technologies citizenship  responsibility overview corporate social responsibility history  innovation leadership overview leadership team board of directors investors overview leadership partners overview suppliers overview supplier diversity newsroom overview news releases customers overview cms competitive bidding frequently asked questions ordering overview kci express® recycling  disposal careers overview search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information overview kci express® overview close menu healthcare professionals health care professionals medical education reimbursement instructions for use clinical evidence grants  fellowships submit an idea administrators health care professionals health care professionals medical education reimbursement instructions for use clinical evidence grants  fellowships submit an idea administrators healthcare professionals discover how our innovative approach to healing and unrivalled portfolio can help patients home healthcare professionals delivering customized solutions across the healing  care continuum our commitment to delivering endtoend solutions proven in clinical studies to help ensure your longterm success how we serve healthcare professionals delivering innovation acelity has a long history of delivering healthcare innovations that can make a difference in the lives of patients and improve the standard of care read more about historyinnovation here   evidence based clinical research through extensive clinical research we continually seek to demonstrate the value of the products and therapies we offer read more about clinical evidence here   collaborative education we work with clinicians to share best practises and deliver a range of educational opportunities in advanced wound care acelity global education alliance browse medical education you may also be interested in product list patient stories reimbursement resources for coding and reimbursement learn more instructions for use library of instructions for use for acelity products browse library clinical evidence library acelity offers a wide range of clinically proven economically beneficial wound healing therapies and technologies designed to deliver positive outcomes for patients and healthcare professionals browse library medical education educational articles and resources for advanced wound care   browse library educational grants  fellowships apply for an educational grant or fellowship fellowships educational grants  product donations investigator initiated studies submit an idea share your ideas with us product ideas can lead to innovations that help improve patient care and quality of life idea submission customers we’re here to help   our dedicated support staff set the standard in customer service we offer a wide range of services and programs designed to provide easy access to our products and therapies   customers clinical solutions for healthcare professionals explore our extensive portfolio of innovative healing solutions  trusted by healthcare professionals around the world wound management wound management open abdomen management open abdomen management epidermal harvesting epidermal harvesting incision management incision management animal health animal health dslprarus en you are leaving acelitycom you are now leaving the acelitycom web site links to other sites are provided as a convenience to users these sites are not affiliated with acelity and acelity accepts no responsibility for their content continue cancel footer navigation healthcare professionals reimbursement instructions for use submit an idea education patient information patient resources patient stories about acelity contact careers brands  core technologies leadership tools kci express® patient bill pay ion healing™ mobile app coding guidelines vac® therapy insurance form message for patients terms of use privacy policy sitemap accessibility help copyright   kci licensing all rights reserved the information included in this web site has been prepared and intended for residents of the united states of america this web site contains information about products which may or may not be available in different countries and if applicable may or may not have received approval or market clearance by a governmental regulatory body for different indications for use please consult individual country sites for approved uses and any applicable restrictions the information on this site is intended for healthcare professionals patients should consult with their healthcare professional providers regarding their specific medical conditions and treatments as well as the information provided on this site including the risks and benefits of certain products and services that may be discussed on this site acelity holdings inc company profile  bloomberg feedback acelity holdings inc public company company profile sector health care industry health care facilities  svcs subindustry health care services acelity holdings inc operates as a holding company the company through its subsidiaries provides services such as wound care regenerative medicine production surgical management and dressings acelity holdings serves its patients worldwide corporate information address po box  san antonio tx  united states phone  fax  web url wwwacelitycom board members chairman company william gumina kinetic concepts inc board members company timothy guertin varian medical systems inc james carlson guidon partners lp john megrue apax partners inc steven dyson apax partners llp show more from the web key executives gaurav s agarwal presbusiness  innovation peter w huntley presemerging markets laura piccinini presdeveloped markets john t bibb exec vpsecygeneral counsel dennis crowley senior vice president david e ball senior vpoperations william f hulse iv butch senior vprisk mgmt gregory kayata greg senior vphuman resources sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data d stock quote  acelity holdings inc  bloomberg markets error could not add to watchlist x  watchlist acelity holdings inc dus unlisted dus is unlisted usd volume  before its here its on the bloomberg terminal learn more volume  current pe ratio ttm  earnings per share usd ttm  market cap usd  shares outstanding  pricesales ttm  dividend indicated gross yield  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later there are currently no press releases for this ticker please check back later profile acelity holdings inc operates as a holding company the company through its subsidiaries provides services such as wound care regenerative medicine production surgical management and dressings acelity holdings serves its patients worldwide address po box san antonio tx united states phone  website wwwacelitycom executives board members gaurav s agarwal presbusiness  innovation peter w huntley presemerging markets laura piccinini presdeveloped markets john t bibb exec vpsecygeneral counsel dennis crowley senior vice president show more acelity holdings inc ipo  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search home  markets  ipos  company ipo overview acelity holdings inc ipo overview news headlines financials  filings experts key data use of proceeds competitors company overview company name acelity holdings inc company address  west interstate san antonio tx  company phone  company website wwwacelitycom ceo joseph f woody employees as of   state of inc tx fiscal year end  status withdrawn  proposed symbol  exchange nyse share price  shares offered  offer amount  total expenses  shares over alloted  shareholder shares offered  shares outstanding  lockup period days  lockup expiration  quiet period expiration  cik  we estimate that we will receive net proceeds of approximately  million from the sale of shares of our common stock in this offering assuming an initial public offering price of  per share which is the midpoint of the price range set forth on the cover page of this prospectus and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us if the underwriters exercise in full their option to purchase additional shares the net proceeds to us will be approximately  million assuming an initial public offering price of  per share which is the midpoint of the price range set forth on the cover page of this prospectus and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us we intend to use the net proceeds from this offering together with the net proceeds from our borrowings under the new senior secured credit facilities and the issuance of the new senior notes to a repay all amounts outstanding under our existing senior secured credit facilities and pay accrued interest applicable premiums and related fees and expenses and b redeem all outstanding aggregate principal amounts of the second lien notes and the unsecured notes and pay accrued interest applicable premiums and related fees and expenses as of june   there was a  million net of  million discount net of accretion of senior dollar term e credit facility due may   or the dollar term e loans outstanding b  million net of  million net of accretion of senior euro term e credit facility due may   or the euro term e loans outstanding c  million net of  million net of accretion of senior term e credit facility due november   or the term e loans outstanding d  million of revolving credit loans outstanding under our revolving credit facility maturing in november   or the revolving credit facility e  million outstanding aggregate principal amount net of discount of  million net of accretion of the second lien notes maturing on november   and f  million outstanding aggregate principal amount net of discount of  million net of accretion of the unsecured notes maturing on november   the  million borrowing under the revolving credit facility was repaid in july  using cash from operations borrowings under i dollar term e loans bear interest at a rate equal to at our election a eurocurrency rate plus  or an adjusted base rate plus  ii euro term e loans bear interest at a rate equal to at our election a eurocurrency rate plus  or an adjusted base rate plus  and iii term e loans bear interest at a rate equal to at our election a eurocurrency rate plus  or an adjusted base rate plus  as of june   dollar term e loans euro term e loans and term e loans had the effective interest rates of   and  respectively interest on the second lien notes accrues at the rate of  per annum and interest on the unsecured notes accrues at the rate of  per annum for a further description of our existing indebtedness being refinanced repaid andor redeemed an increase decrease of  shares from the expected number of shares to be sold by us in this offering assuming no change in the assumed initial offering price per share which is the midpoint of the price range set forth on the cover page of this prospectus would increase decrease our net proceeds from this offering by  million a  increase decrease in the assumed initial offering price of  per share based on the midpoint of the price range set forth on the cover page of this prospectus would increase decrease the net proceeds to us from this offering by  million assuming the number of shares offered by us as set forth on the cover page of this prospectus remains the same and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us our currently marketed products are and any future products we commercialize will be subject to intense competition we believe that the principal competitive factors in our markets are • quality reliability and ease of use • price • differentiated product features that deliver superior clinical outcomes and economic value • clinical support and education for customers on product use and clinical practice • innovation capabilities to bring new products to market that meet customer needs • dedicated aroundtheclock customer service for technical clinical and reimbursement support and • deeprooted relationships with customers and buyers our awt products compete with various commercially available negative pressure therapy products as well as other traditional modalities in wound care key competitors to our awt business include m health care ltd cardinal health inc coloplast corp convatec inc mimedx group inc mölnlycke health care organogenesis inc smith  nephew plc and the hartmann group in addition there are several smaller regional companies that have introduced medical devices designed to compete with our awt products our regenerative medicine products compete with various commercially available products made from synthetic materials or biologic materials of human or animal tissue origin our tissue matrix products compete with products marketed by such companies as allergan plc atrium medical corporation baxter international inc cook inc covidien plc cr bard inc johnson  johnson tei biosciences inc and wl gore  associates inc in addition there are several smaller companies that have introduced synthetic or biologic materials designed to compete with our regenerative medicine products we also compete in the marketplace to recruit and retain qualified scientific management and sales personnel as well as to acquire technologies and technology licenses complementary to our products or advantageous to our business we are aware of several companies that compete or are developing technologies in our current and future product areas as a result we expect competition to remain intense our ability to compete successfully will depend on our ability to develop proprietary products that reach the market in a timely manner receive adequate coverage and reimbursement are cost effective and are safe and effective company description acelity is a leading global medical technology company committed to the development and commercialization of advanced wound care and regenerative medicine solutions acelity was formed by uniting the strengths of three organizations kci systagenix and lifecell into our two business segments advanced wound therapeutics and regenerative medicine our mission is to change the clinical practice of medicine with solutions that speed healing reduce complications create economic value and improve patients’ lives we are global pioneers in advanced wound care and soft tissue repair creating and growing new markets based on our ability to identify and address unmet clinical needs with products that advance the practice of medicine beginning with our introduction of groundbreaking negative pressure wound therapy or npwt and acellular tissue matrices nearly  years ago we offer a broad range of products that can be used across clinical applications care settings and clinician groups to accelerate soft tissue healing improve clinical outcomes and reduce overall costs of care our product offerings are backed by an extensive body of scientific clinical and economic outcomes data that demonstrate the clinical efficacy and value proposition of our products by offering a range of complementary solutions that are often used together or in sequence across multiple care settings we are able to address patients’ needs throughout the healing process and offer healthcare providers a single source for addressing such needs we have maintained our market leadership by capitalizing on our differentiated and bestinclass product offerings utilizing our highly trained sales force robust service infrastructure and strong clinical reputation our advanced wound therapeutics or awt business is focused on the development and commercialization of advanced devices and advanced wound dressings our advanced devices business is primarily engaged in marketing several technology platforms including npwt surgical and incision management and epidermal grafting for patients suffering from traumatic surgical or chronic wounds such as diabetic foot ulcers our npwt devices facilitate accelerated healing that was unattainable prior to the introduction of npwt our advanced wound dressings business markets wound dressing technologies for the purpose of managing chronic and acute wounds our advanced wound dressings are designed to maintain a moist wound environment while managing exudate to promote healing and to protect the wound site from infection our awt business is primarily conducted by kci and its operating subsidiaries including systagenix our regenerative medicine business is primarily focused on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in general and reconstructive surgical procedures to reinforce soft tissue defects we offer tissue matrices for a variety of reconstructive procedures including postmastectomy breast reconstruction and the reinforcement of abdominal wall defects our tissue matrices are engineered to encourage rapid tissue incorporation reducing morbidity for patients while providing optimal reconstructive outcomes in addition to our acellular tissue matrices our regenerative medicine business markets complementary autologous fat grafting solutions for reconstructive and aesthetic applications our regenerative medicine business is primarily conducted by lifecell and its operating subsidiaries we are a global company with approximately  of our  revenues generated outside the united states and our products are available in more than  countries we have invested in direct sales and marketing channels and distributors in order to expand our presence in these markets to meet the needs of our customers and payers across clinical applications care settings and clinician groups a critical component of marketing our portfolio of solutions and services is our sales organization of approximately  professionals working across multiple care settings and specialties of which approximately  are based in the united states this sales infrastructure enables us to market our products directly with trained medical professionals in specific care settings in the united states canada western europe and key emerging markets we have succeeded in establishing strong relationships globally with key constituencies including hospitals postacute facilities group purchasing organizations or gpos payers and other key clinical and economic decision makers by offering comprehensive customer service and clinical education  acelity holdings inc was incorporated in texas on august   our principal offices are located at  west interstate  san antonio texas  our telephone number is   we maintain a website at wwwacelitycom full description the ipo profiles may contain historical records please visit the latest ipos for the most recent information company financials revenue  net income  total assets  total liabilities  stockholders equity  company filings viewing    total  company name form type date received view acelity holdings inc rw  filing acelity holdings inc sa  filing acelity holdings inc s  filing experts auditor ernst  young llp company counsel simpson thacher  bartlett llp and winstead pc company counsel winstead pc and simpson thacher  bartlett llp lead underwriter bofa merrill lynch lead underwriter goldman sachs  co lead underwriter jp morgan securities llc transfer agent  underwriter barclays capital inc underwriter credit suisse securities usa llc underwriter morgan stanley  co llc underwriter rbc capital markets llc underwriter ubs investment bank underwriter counsel kirkland  ellis llp there are no news stories for this ipo at this time todays market activity nasdaq    ▲   djia    ▲   sp     ▲   data as of jul   try for free nasdaq livequotes platform view all latest news headlines randolph bancorp inc announces second quarter and yeartodate  financial results pm et   globenewswire refilehalliburton schlumberger take hit on venezuela bills in second quarter pm et   reuters form holdings announces proposed public offering of common stock pm et   globenewswire us judge refuses to halt new york nuclear power plant subsidies pm et   reuters view all latest headlines upcoming earnings company expected report date aapl jul   odfl jul   fb jul   tsla aug   t jul   amzn jul   vz jul   ge jul   earnings calendar closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex acelity  wound management acelity site navigation investors leadership partners suppliers newsroom news releases customers cms competitive bidding frequently asked questions ordering recycling  disposal careers search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information kci express® products products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology featured products tielle™ dressing family activac™ therapy system with ion progress™ remote therapy monitoring biosorb™ gelling fiber dressing vaculta™ negative pressure wound therapy system promogran prisma™ matrix prevena™ incision management system healthcare professionals healthcare professionals overview medical education reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients patients overview patient stories about about overview compliance mission and values our brands  core technologies citizenship  responsibility history  innovation leadership menu search acelity products overview clinical solutions wound management open abdomen management incision management epidermal harvesting animal health product information product catalog product technology healthcare professionals overview medical education overview medical education programs reimbursement instructions for use clinical evidence cms competitive bidding grants  fellowships investigator initiated studies submit an idea administrators patients overview patient stories about overview compliance mission and values our brands  core technologies citizenship  responsibility overview corporate social responsibility history  innovation leadership overview leadership team board of directors investors overview leadership partners overview suppliers overview supplier diversity newsroom overview news releases customers overview cms competitive bidding frequently asked questions ordering overview kci express® recycling  disposal careers overview search jobs job seeker faq san antonio hq featured jobs internships talent community usa contact information overview kci express® overview close menu wound management wound management diabetic foot ulcers pressure ulcers venous leg ulcers acute  traumatic wounds infected wounds enteric fistulas wound management wound management diabetic foot ulcers pressure ulcers venous leg ulcers acute  traumatic wounds infected wounds enteric fistulas wound management helping patients heal why it matters clinician resources view all products home products wound management helping patients heal our focus is to make patients better our products have been clinically evaluated and shown to facilitate healing in the hospital or the home acelity has developed a comprehensive range of products and therapies for a wide variety of wounds the science behind our products our solutions are built on deep scientific expertise supported by a large body of clinical evidence product technology clinical evidence why it matters chronic wounds represent a large and growing threat to public health in the us alone they affect over  million people as the population ages that burden will increase – made worse by rising healthcare costs and the growing incidences of diabetes and obesity   at acelity we help improve the lives of patients through innovation we are also researching and documenting the value of our products in terms of individual and public benefit this research helps to inform policy and decisionmakers by providing a systematic way to evaluate different treatments   diabetic foot ulcers every  seconds a leg is amputated globally due to diabetes for patients diagnosed with diabetes mellitus the lifetime risk of developing a foot ulcer may be as high as  of this  of diabetic foot ulcers progress to amputation accounting for  of nontraumatic amputations   explore focus area   featured products snap™ therapy system promogran prisma™ matrix activac™ therapy system pressure ulcers a pressure ulcer also known as a bed sore pressure sore or decubitus ulcer is a localized injury to the skin andor underlying tissue which may be caused by unrelieved pressure on the skin    these pressure induced skin injuries range from non blanchable erythema of intact skin to deep ulcers extending to the bone where ulceration may be determined by the degree and duration of pressure and may be characterized by deep tissue necrosis it usually occurs over a bony prominence as a result of pressure shear or friction acelity offers a comprehensive range of products for the management of pressure ulcers   explore focus area   featured products snap™ therapy system promogran prisma™ matrix activac™ therapy system venous leg ulcers venous ulcers are most commonly found below the knee and above the ankle and often have a larger surface area but are shallower in depth than other ulcers the leg may become swollen causing the skin surrounding the ulcer to become dry itchy and sometimes brownish in color   explore focus area featured products snap™ therapy system dynaflex™ compression system vaculta™ therapy system acute  traumatic wounds acute wounds are disruptions to the integrity of the skin and underlying tissues that with proper care and control heal in a timely and uneventful manner traumatic wounds result from injury to hard andor soft tissue and include damage to bone muscle ligament and tendons including partial thickness burns and orthopedic wounds   explore focus area featured products vaculta™ therapy system tielle™ plus dressing adaptic™ dressing infected wounds infected wounds cant wait every infected wound requires a comprehensive treatment plan to help manage the wound and reestablish an environment for healing   explore focus area featured products vaculta™ therapy system vac® granufoam silver™ dressings silvercel™ nonadherent dressing enteric fistulas fistulas are an abnormal connection between two or more structures or spaces fistulas are usually the result of injury or surgery but also can result from infection or inflammation managing patients with fistulas is challenging and represents a significant unmet need   explore focus area   featured products fistula solution® devices clinician resources acelity offers a wide range of wound healing solutions such as vac® therapy and advanced wound dressings acelity is a trusted partner offering clinically proven economically beneficial wound healing therapies designed to deliver positive outcomes for patients and healthcare professionals   learn more for clinicians chronic wounds solutions brochure vac® therapy essentials acelity wound selection guide tielle™ dressing family overview healthcare professionals for patients patient resources vac® therapy patient guide vacvia™ patient guide cellutome™ patient brochure a patient’s perspective patients help others by sharing their stories on how acelity products have helped them patients stories   click here to view references  sen et al wound repair regen    –     singh n armstrong dg lipsky ba preventing foot ulcers in patients with diabetes jama  jan  review   dsldslus you are leaving acelitycom you are now leaving the acelitycom web site links to other sites are provided as a convenience to users these sites are not affiliated with acelity and acelity accepts no responsibility for their content continue cancel footer navigation healthcare professionals reimbursement instructions for use submit an idea education patient information patient resources patient stories about acelity contact careers brands  core technologies leadership tools kci express® patient bill pay ion healing™ mobile app coding guidelines vac® therapy insurance form message for patients terms of use privacy policy sitemap accessibility help copyright   kci licensing all rights reserved the information included in this web site has been prepared and intended for residents of the united states of america this web site contains information about products which may or may not be available in different countries and if applicable may or may not have received approval or market clearance by a governmental regulatory body for different indications for use please consult individual country sites for approved uses and any applicable restrictions the information on this site is intended for healthcare professionals patients should consult with their healthcare professional providers regarding their specific medical conditions and treatments as well as the information provided on this site including the risks and benefits of certain products and services that may be discussed on this site bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version acelity holdings inc ipo experts  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search home  markets  ipos  company ipo experts acelity holdings inc ipo overview news headlines financials  filings experts key data use of proceeds competitors company overview company name acelity holdings inc company address  west interstate san antonio tx  company phone  company website wwwacelitycom ceo joseph f woody employees as of   state of inc tx fiscal year end  status withdrawn  proposed symbol  exchange nyse share price  shares offered  offer amount  total expenses  shares over alloted  shareholder shares offered  shares outstanding  lockup period days  lockup expiration  quiet period expiration  cik  we estimate that we will receive net proceeds of approximately  million from the sale of shares of our common stock in this offering assuming an initial public offering price of  per share which is the midpoint of the price range set forth on the cover page of this prospectus and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us if the underwriters exercise in full their option to purchase additional shares the net proceeds to us will be approximately  million assuming an initial public offering price of  per share which is the midpoint of the price range set forth on the cover page of this prospectus and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us we intend to use the net proceeds from this offering together with the net proceeds from our borrowings under the new senior secured credit facilities and the issuance of the new senior notes to a repay all amounts outstanding under our existing senior secured credit facilities and pay accrued interest applicable premiums and related fees and expenses and b redeem all outstanding aggregate principal amounts of the second lien notes and the unsecured notes and pay accrued interest applicable premiums and related fees and expenses as of june   there was a  million net of  million discount net of accretion of senior dollar term e credit facility due may   or the dollar term e loans outstanding b  million net of  million net of accretion of senior euro term e credit facility due may   or the euro term e loans outstanding c  million net of  million net of accretion of senior term e credit facility due november   or the term e loans outstanding d  million of revolving credit loans outstanding under our revolving credit facility maturing in november   or the revolving credit facility e  million outstanding aggregate principal amount net of discount of  million net of accretion of the second lien notes maturing on november   and f  million outstanding aggregate principal amount net of discount of  million net of accretion of the unsecured notes maturing on november   the  million borrowing under the revolving credit facility was repaid in july  using cash from operations borrowings under i dollar term e loans bear interest at a rate equal to at our election a eurocurrency rate plus  or an adjusted base rate plus  ii euro term e loans bear interest at a rate equal to at our election a eurocurrency rate plus  or an adjusted base rate plus  and iii term e loans bear interest at a rate equal to at our election a eurocurrency rate plus  or an adjusted base rate plus  as of june   dollar term e loans euro term e loans and term e loans had the effective interest rates of   and  respectively interest on the second lien notes accrues at the rate of  per annum and interest on the unsecured notes accrues at the rate of  per annum for a further description of our existing indebtedness being refinanced repaid andor redeemed an increase decrease of  shares from the expected number of shares to be sold by us in this offering assuming no change in the assumed initial offering price per share which is the midpoint of the price range set forth on the cover page of this prospectus would increase decrease our net proceeds from this offering by  million a  increase decrease in the assumed initial offering price of  per share based on the midpoint of the price range set forth on the cover page of this prospectus would increase decrease the net proceeds to us from this offering by  million assuming the number of shares offered by us as set forth on the cover page of this prospectus remains the same and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us our currently marketed products are and any future products we commercialize will be subject to intense competition we believe that the principal competitive factors in our markets are • quality reliability and ease of use • price • differentiated product features that deliver superior clinical outcomes and economic value • clinical support and education for customers on product use and clinical practice • innovation capabilities to bring new products to market that meet customer needs • dedicated aroundtheclock customer service for technical clinical and reimbursement support and • deeprooted relationships with customers and buyers our awt products compete with various commercially available negative pressure therapy products as well as other traditional modalities in wound care key competitors to our awt business include m health care ltd cardinal health inc coloplast corp convatec inc mimedx group inc mölnlycke health care organogenesis inc smith  nephew plc and the hartmann group in addition there are several smaller regional companies that have introduced medical devices designed to compete with our awt products our regenerative medicine products compete with various commercially available products made from synthetic materials or biologic materials of human or animal tissue origin our tissue matrix products compete with products marketed by such companies as allergan plc atrium medical corporation baxter international inc cook inc covidien plc cr bard inc johnson  johnson tei biosciences inc and wl gore  associates inc in addition there are several smaller companies that have introduced synthetic or biologic materials designed to compete with our regenerative medicine products we also compete in the marketplace to recruit and retain qualified scientific management and sales personnel as well as to acquire technologies and technology licenses complementary to our products or advantageous to our business we are aware of several companies that compete or are developing technologies in our current and future product areas as a result we expect competition to remain intense our ability to compete successfully will depend on our ability to develop proprietary products that reach the market in a timely manner receive adequate coverage and reimbursement are cost effective and are safe and effective company description acelity is a leading global medical technology company committed to the development and commercialization of advanced wound care and regenerative medicine solutions acelity was formed by uniting the strengths of three organizations kci systagenix and lifecell into our two business segments advanced wound therapeutics and regenerative medicine our mission is to change the clinical practice of medicine with solutions that speed healing reduce complications create economic value and improve patients’ lives we are global pioneers in advanced wound care and soft tissue repair creating and growing new markets based on our ability to identify and address unmet clinical needs with products that advance the practice of medicine beginning with our introduction of groundbreaking negative pressure wound therapy or npwt and acellular tissue matrices nearly  years ago we offer a broad range of products that can be used across clinical applications care settings and clinician groups to accelerate soft tissue healing improve clinical outcomes and reduce overall costs of care our product offerings are backed by an extensive body of scientific clinical and economic outcomes data that demonstrate the clinical efficacy and value proposition of our products by offering a range of complementary solutions that are often used together or in sequence across multiple care settings we are able to address patients’ needs throughout the healing process and offer healthcare providers a single source for addressing such needs we have maintained our market leadership by capitalizing on our differentiated and bestinclass product offerings utilizing our highly trained sales force robust service infrastructure and strong clinical reputation our advanced wound therapeutics or awt business is focused on the development and commercialization of advanced devices and advanced wound dressings our advanced devices business is primarily engaged in marketing several technology platforms including npwt surgical and incision management and epidermal grafting for patients suffering from traumatic surgical or chronic wounds such as diabetic foot ulcers our npwt devices facilitate accelerated healing that was unattainable prior to the introduction of npwt our advanced wound dressings business markets wound dressing technologies for the purpose of managing chronic and acute wounds our advanced wound dressings are designed to maintain a moist wound environment while managing exudate to promote healing and to protect the wound site from infection our awt business is primarily conducted by kci and its operating subsidiaries including systagenix our regenerative medicine business is primarily focused on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in general and reconstructive surgical procedures to reinforce soft tissue defects we offer tissue matrices for a variety of reconstructive procedures including postmastectomy breast reconstruction and the reinforcement of abdominal wall defects our tissue matrices are engineered to encourage rapid tissue incorporation reducing morbidity for patients while providing optimal reconstructive outcomes in addition to our acellular tissue matrices our regenerative medicine business markets complementary autologous fat grafting solutions for reconstructive and aesthetic applications our regenerative medicine business is primarily conducted by lifecell and its operating subsidiaries we are a global company with approximately  of our  revenues generated outside the united states and our products are available in more than  countries we have invested in direct sales and marketing channels and distributors in order to expand our presence in these markets to meet the needs of our customers and payers across clinical applications care settings and clinician groups a critical component of marketing our portfolio of solutions and services is our sales organization of approximately  professionals working across multiple care settings and specialties of which approximately  are based in the united states this sales infrastructure enables us to market our products directly with trained medical professionals in specific care settings in the united states canada western europe and key emerging markets we have succeeded in establishing strong relationships globally with key constituencies including hospitals postacute facilities group purchasing organizations or gpos payers and other key clinical and economic decision makers by offering comprehensive customer service and clinical education  acelity holdings inc was incorporated in texas on august   our principal offices are located at  west interstate  san antonio texas  our telephone number is   we maintain a website at wwwacelitycom full description the ipo profiles may contain historical records please visit the latest ipos for the most recent information company financials revenue  net income  total assets  total liabilities  stockholders equity  company filings viewing    total  company name form type date received view acelity holdings inc rw  filing acelity holdings inc sa  filing acelity holdings inc s  filing experts auditor ernst  young llp company counsel simpson thacher  bartlett llp and winstead pc company counsel winstead pc and simpson thacher  bartlett llp lead underwriter bofa merrill lynch lead underwriter goldman sachs  co lead underwriter jp morgan securities llc transfer agent  underwriter barclays capital inc underwriter credit suisse securities usa llc underwriter morgan stanley  co llc underwriter rbc capital markets llc underwriter ubs investment bank underwriter counsel kirkland  ellis llp there are no news stories for this ipo at this time todays market activity nasdaq    ▲   djia    ▲   sp     ▲   data as of jul   try for free nasdaq livequotes platform view all latest news headlines randolph bancorp inc announces second quarter and yeartodate  financial results pm et   globenewswire refilehalliburton schlumberger take hit on venezuela bills in second quarter pm et   reuters form holdings announces proposed public offering of common stock pm et   globenewswire us judge refuses to halt new york nuclear power plant subsidies pm et   reuters view all latest headlines upcoming earnings company expected report date aapl jul   odfl jul   fb jul   tsla aug   t jul   amzn jul   vz jul   ge jul   earnings calendar closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex acelity holdings inc  company profile  biocentury publications archives bciq conferences version  free trial  subscribe sign in english   한국어 biocentury menu home  publications  publications home  biocentury bc innovations bc extra bc week in review current issues archives  archives home  basic search advanced search back issues bciq  bciq home  overview pipeline analyst financial analyst company analyst deal analyst conferences  conferences home  newsmakers bio€quity europe future leaders china healthcare summit other industry events elearning  elearning home  videos white papers follow us bciq  company profile bciq overview      settings      support biocentury print this       acelity holdings inc print preview export bookmark share with colleague general information  location san antonio texas  region texas  country us  business category dermatology transplant  year founded   website httpwwwacelitycom  lead product status market drug  archive items are loading  financial information  financing summary  financing details  earnings summary  stocks annual chart  pipeline information  pipeline summary  pipeline details  deals information  deals summary  deals details about biocentury company overview management editorial  research contact contact us advertising  sponsorship career opportunities support forgot password customer service reprints faqs products  solutions products overview publications archives bciq conferences elearning rss feeds legal user agreement terms of use privacy policy your california privacy rights use of images follow us what is biocentury biocentury employs a fully integrated multimedia platform — including publications video online data solutions and conferences — to provide its audience with authoritative and uptodate intelligence about corporate strategy partnering emerging technology clinical data public policy and the financial markets sign in free trial   biocentury inc all rights reserved    terms  conditions  privacy policy set email alert dummy acelity holdings expects to raise  billion in ipo  reuters discover thomson reutersfinancialgovernment solutionslegalreuters news agencyrisk management solutionstax  accountingblog answers oninnovation  thomson reutersdirectory of siteslogincontactsupport years agoacelity holdings expects to raise  billion in iposessionstrumpearningshealthcarecyberriskfutureofmoneyenergyenvironmentsectionsbusinessmarketsworldpoliticstechcommentarybreakingviewsmoneylifepicturesreuters tvdiscover thomson reutersfinancialgovernment solutionslegalreuters news agencyrisk management solutionstax  accountingblog answers oninnovation  thomson reutersdirectory of siteslogincontactsupportfeaturedpoliticsrepublican lawmakers rally around sessionsrussiahouse approves new russia sanctions defying trumpussurvivors of texas truck where  died offer testimony for visaspicturesreuters tveditionunited statesafricaamérica latinaعربيargentinabrasilcanadadeutschlandespañafranceindiaitaliaméxicoроссияunited kingdomunited statesdealsoctober     pm   years agoacelity holdings expects to raise  billion in ipo min readreuters  medical technology company acelity holdings inc ipoachln expects to raise up to  billion in its ipo according to a filing with the us securities and exchange commission the san antonio texasbased company which develops regenerative medicine and sells health care products in  countries filed for an initial public offering in august the company is a portfolio company of private equity firm apax partners canadian pension investment manager psp investments and the canada pension plan board acelity was founded in  as kinetic concepts inc kci kci acquired lifecell corp for  billion in  and bought ukbased systagenix formerly a part of johnson  johnson jnjn for  million in  kci renamed itself as acelity after the systagenix takeover the company was leveraged at x at june  and plans to use the ipo to repay its debt thomson reuters ifr reported in august acelity intends to list on the new york stock exchange but has yet to decide on a ticker symbol the company has not revealed the number of shares it will be offering or their expected price the company which generated  billion in revenue last year sells and rents its negative pressure wound therapy systems for use in surgical procedures such as postmastectomy breast reconstruction and abdominal wall reconstructions jp morgan goldman sachs and bank of america merrill lynch are the topline bookrunners while morgan stanley barclays credit suisse rbc capital markets and ubs are joint bookrunners reporting by rachel chitra in bengaluru editing by don sebastian and maju samuel  narrowbrowserandphonemediumbrowserandportraittabletlandscapetabletmediumwidebrowserwidebrowserandlargermediumbrowserandlandscapetabletmediumwidebrowserandlargerabovephoneportraittabletandaboveaboveportraittabletlandscapetabletandabovelandscapetabletandmediumwidebrowserportraittabletandbelowlandscapetabletandbelowappsnewslettersreuters plusadvertising guidelinescookiesterms of useprivacyall quotes delayed a minimum of  minutes see here for a complete list of exchanges and delays  reuters all rights reserved acelity files registration statement for proposed initial public offering  business wire acelity files registration statement for proposed initial public offering august    am eastern daylight time san antoniobusiness wireacelity holdings inc “acelity” today announced that it has filed a registration statement on form s with the us securities and exchange commission relating to a proposed initial public offering of its common stock the number of shares to be offered and the price range for the proposed offering have not yet been determined acelity is a whollyowned subsidiary of acelity lp inc and in connection with this offering acelity will become the parent company of acelity lp inc’s advanced wound care and regenerative medicine businesses jp morgan goldman sachs  co and bofa merrill lynch are acting as joint bookrunning managers for the proposed offering the offering will be made only by means of a prospectus when available a copy of the preliminary prospectus related to the offering may be obtained from jp morgan securities llc attention prospectus department co broadridge financial solutions  long island avenue edgewood ny  via telephone  goldman sachs  co attention prospectus department  west street new york ny  via telephone  or by facsimile at  or via email prospectusnynyemailgscom or bofa merrill lynch attn prospectus department at  broadway new york ny  or by email at dgprospectusrequestsbamlcom a registration statement relating to these securities has been filed with the us securities and exchange commission but has not yet become effective these securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective this press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities nor shall there be any sale of these securities in any state or jurisdiction in which such an offer solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction about acelity acelity lp inc and its subsidiaries are a global advanced wound care and regenerative medicine company created by uniting the strengths of three companies kinetic concepts inc lifecell corporation and systagenix wound management limited available in more than  countries the innovative and complementary acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality safety and customer experience headquartered in san antonio texas acelity employs more than  people around the world contacts media contactsacelitycheston turbyfill orbrunswick groupjayne rosefield  lauren nadig orinvestor relations contactacelitycaleb moorecalebmooreacelitycom release summary acelity files registration statement for proposed initial public offering contacts media contactsacelitycheston turbyfill orbrunswick groupjayne rosefield  lauren nadig orinvestor relations contactacelitycaleb moorecalebmooreacelitycom search advanced news search advanced news search log in sign up